[骨与关节疾病的流行病学——现状与未来——肌肉减少症的流行病学]

[Epidemiology of bone and joint disease - the present and future - . Epidemiology of sarcopenia].

作者信息

Harada Atsushi

机构信息

National Center for Geriatrics and Gerontology, Japan.

出版信息

Clin Calcium. 2014 May;24(5):669-78.

PMID:24769677

Abstract

The prevalence of sarcopenia diagnosed only by muscle mass in the elderly ranged from 12% to 50%, when muscle mass was measured by DXA with high accuracy. In Japanese elderly, it was reportedly 12%, 24%, 40%, and 53% in the 50s, 60s, 70s, and 80s men, respectively, and 24%, 21%, 24%, and 25% in the 50s, 60s, 70s, and 80s women, respectively. Recently, as new criteria including physical performance such as gait speed, and muscle strength, two international consensuses were obtained in Europe and US. In addition, Asian criteria have also been decided most recently. The prevalence of sarcopenia in Japanese people aged 65 years or over diagnosed using European criteria, was reportedly 10% and 22% in men, and 15% and 22% in women. The future development of epidemiological studies for sarcopenia is awaited.

摘要

仅通过肌肉量诊断的老年人肌少症患病率在12%至50%之间，此时采用双能X线吸收法（DXA）能高精度测量肌肉量。据报道，在日本老年人中，50多岁、60多岁、70多岁和80多岁男性的肌少症患病率分别为12%、24%、40%和53%，50多岁、60多岁、70多岁和80多岁女性的患病率分别为24%、21%、24%和25%。最近，随着包括步态速度和肌肉力量等身体表现的新诊断标准出台，欧美达成了两项国际共识。此外，亚洲标准也于近期确定。据报道，采用欧洲标准诊断的65岁及以上日本人群中，男性肌少症患病率为10%和22%，女性为15%和22%。期待肌少症流行病学研究的未来发展。